Jayagopal Ashwath 4
4 · Ocuphire Pharma, Inc. · Filed Feb 14, 2024
Insider Transaction Report
Form 4
Jayagopal Ashwath
Chief Scientific & Dev. Ofc.
Transactions
- Award
Common Stock
2024-02-12+75,000→ 75,000 total - Award
Employee Stock Option (right to buy)
2024-02-12+225,000→ 225,000 totalExercise: $2.66Exp: 2034-02-11→ Common Stock (225,000 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of February 12, 2024, subject to the Reporting Person's continuing service.
- [F2]The option will vest with respect to 25% on February 12, 2025, with the remaining shares vesting quarterly in 12 equal installments thereafter, subject to the Reporting Person's continuing service.